BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND ECT2L, 345930, C6orf91, Q008S8, LFDH, dJ509I19_3, dJ509I19_2, ENSG00000203734 AND Treatment
45969 results:

  • 1. Vasorin promotes endothelial differentiation of glioma stem cells via stimulating the transcription of VEGFR2.
    Qin Z; Zhong Y; Li P; Ma Z; Kang H; Huang Y; Zhong Y; Wang L
    FASEB J; 2024 May; 38(10):e23682. PubMed ID: 38780524
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Long-term outcome and fertility results of intraplacental choriocarcinoma: a retrospective study of 14 patients and literature review.
    Liu Y; Song X; Zhang H; Feng F; Zhao J; Yang J; Ren T; Wan X; Jiang F; Li Y; Xiang Y
    Orphanet J Rare Dis; 2024 May; 19(1):214. PubMed ID: 38778412
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Characteristics and significance of programmed cell death-related gene expression signature in skin cutaneous melanoma.
    Wu X; Chen S; Ji Q; Chen H; Chen X
    Skin Res Technol; 2024 May; 30(5):e13739. PubMed ID: 38766879
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Mortality trend of cutaneous melanoma in Montenegro from 1990-2018.
    Nedovic Vukovic M; Terzic Z; Golubovic M; Bojic M; Bukumiric Z
    Eur Rev Med Pharmacol Sci; 2024 May; 28(9):3463-3472. PubMed ID: 38766804
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Risk factor analysis and nomogram development and verification for medullary carcinoma of the colon using SEER database.
    Yang L; Yu L; Zhou Q; Liu L; Shen N; Li N
    Sci Rep; 2024 May; 14(1):11426. PubMed ID: 38763982
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. IDH1 mutation produces R-2-hydroxyglutarate (R-2HG) and induces mir-182-5p expression to regulate cell cycle and tumor formation in glioma.
    Zhao H; Meng L; Du P; Liao X; Mo X; Gong M; Chen J; Liao Y
    Biol Res; 2024 May; 57(1):30. PubMed ID: 38760850
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Dual-targeted delivery of temozolomide by multi-responsive nanoplatform via tumor microenvironment modulation for overcoming drug resistance to treat glioblastoma.
    Chen X; Zheng Y; Zhang Q; Chen Q; Chen Z; Wu D
    J Nanobiotechnology; 2024 May; 22(1):264. PubMed ID: 38760771
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors.
    Lin AL; Rudneva VA; Richards AL; Zhang Y; Woo HJ; Cohen M; Tisnado J; Majd N; Wardlaw SL; Page-Wilson G; Sengupta S; Chow F; Goichot B; Ozer BH; Dietrich J; Nachtigall L; Desai A; Alano T; Ogilive S; Solit DB; Bale TA; Rosenblum M; Donoghue MTA; Geer EB; Tabar V
    Acta Neuropathol; 2024 May; 147(1):85. PubMed ID: 38758238
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Multi-omic analysis identifies hypoalbuminemia as independent biomarker of poor outcome upon PD-1 blockade in metastatic melanoma.
    Leek LVM; Notohardjo JCL; de Joode K; Velker EL; Haanen JBAG; Suijkerbuijk KPM; Aarts MJB; de Groot JWB; Kapiteijn E; van den Berkmortel FWPJ; Westgeest HM; de Gruijl TD; Retel VP; Cuppen E; van der Veldt AAM; Labots M; Voest EE; van de Haar J; van den Eertwegh AJM
    Sci Rep; 2024 May; 14(1):11244. PubMed ID: 38755213
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Singular Value Decomposition-Based Penalized Multinomial Regression for Classifying Imbalanced Medulloblastoma Subgroups Using Methylation Data.
    Mohammed I; Elbashir MK; Faggad AS
    J Comput Biol; 2024 May; 31(5):458-471. PubMed ID: 38752890
    [No Abstract]    [Full Text] [Related]  

  • 11. Knockdown of trem2 promotes proinflammatory microglia and inhibits glioma progression via the JAK2/STAT3 and NF-κB pathways.
    Yan Y; Bai S; Han H; Dai J; Niu L; Wang H; Dong Q; Yin H; Yuan G; Pan Y
    Cell Commun Signal; 2024 May; 22(1):272. PubMed ID: 38750472
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Safety and efficacy of peptide receptor radionuclide therapy in neuroendocrine tumors: A single center experience.
    Sukrithan V; Armbruster H; Rogers S; Vogt SM; Grenade C; Verschraegen C; Zhou Y; Goyal A; Natwa M; Hussein A; Barr H; Konate D; Batdorf R; Brown A; Williams B; Zhao S; Wei L; Xu M; Shah MH; Konda B
    PLoS One; 2024; 19(5):e0298824. PubMed ID: 38748739
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. METTL8 links mt-tRNA m
    Lee BWL; Chuah YH; Yoon J; Grinchuk OV; Liang Y; Hirpara JL; Shen Y; Wang LC; Lim YT; Zhao T; Sobota RM; Yeo TT; Wong ALA; Teo K; Nga VDW; Tan BWQ; Suda T; Toh TB; Pervaiz S; Lin Z; Ong DST
    Cell Death Dis; 2024 May; 15(5):338. PubMed ID: 38744809
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prognostic nomogram in middle-aged and elderly patients with chordoma: A SEER-based study.
    Ouyang C; Sun Y; Li Y; Jiang M; Nong L; Gao G
    J Orthop Surg (Hong Kong); 2024; 32(2):10225536241254208. PubMed ID: 38744697
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Deciphering the causal relationship between plasma and cerebrospinal fluid metabolites and glioblastoma multiforme: a Mendelian Randomization study.
    Zhou Z; Leng H
    Aging (Albany NY); 2024 May; 16(9):8306-8319. PubMed ID: 38742944
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Transformation of IDH-wildtype glioblastoma to gliosarcoma with features of osteosarcoma.
    Sobczyk P; Sobstyl M; Acewicz A; Rosa J; Grabiec M; Grajkowska W
    Folia Neuropathol; 2024; 62(1):96-101. PubMed ID: 38741436
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Association of 5-aminolevulinic acid fluorescence guided resection with photodynamic therapy in recurrent glioblastoma: a matched cohort study.
    da Silva EB; Vasquez MWM; de Almeida Teixeira BC; Neto MC; Sprenger F; Filho JLN; Almeida-Lopes L; Ramina R
    Acta Neurochir (Wien); 2024 May; 166(1):212. PubMed ID: 38739282
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Predicting the effectiveness of organ-preserving treatment of choroidal melanoma using optical coherence tomography data].
    Stoyukhina AS
    Vestn Oftalmol; 2024; 140(2. Vyp. 2):16-20. PubMed ID: 38739126
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Discovery of Novel Small-Molecule-Based Potential PD-L1/EGFR Dual Inhibitors with High Druggability for Glioblastoma Immunotherapy.
    Yang Z; Liu Z; Wan S; Xu J; Huang Y; He H; Liu T; Li L; Ren Y; Zhang J; Chen J
    J Med Chem; 2024 May; 67(10):7995-8019. PubMed ID: 38739112
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [A rare cause of hypercorticism: ACTH-secreting pheochromocytoma (a case report)].
    Rifai K; Toulali F; Iraqi H; Ettaik M; Gharbi MEH
    Pan Afr Med J; 2024; 47():88. PubMed ID: 38737225
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2299.